Higher‐dose anticoagulants vs lower‐dose anticoagulants
Adverse events (minor bleeding) · people hospitalised with COVID‐19
Higher‐dose anticoagulants leads to higher adverse events (minor bleeding) compared with lower‐dose anticoagulants (high certainty).
1 finding from 1 review
- Anticoagulants for people hospitalised with COVID‐19: a rapid review 2022 · Cochrane Headline outcomes onlyRR 3.28 [1.75, 6.14]3 studies · 1196 participantsHigh